Skip to main content
IDEX Biometrics ASA logo

IDEX Biometrics ASA — Investor Relations & Filings

Ticker · IDEX ISIN · NO0013107490 LEI · 5967007LIEEXZXHECW11 OL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 1,321 across all filing types
Latest filing 2022-12-09 AGM Information
Country NO Norway
Listing OL IDEX

About IDEX Biometrics ASA

https://www.idexbiometrics.com/

IDEX Biometrics ASA is a technology company specializing in fingerprint identification and biometric authentication solutions. The company designs, develops, and commercializes proprietary fingerprint sensors and software for integration into smart cards. Its core products are biometric payment cards and access cards, which provide enhanced security for financial transactions and identity verification. The technology stores and matches the user's fingerprint data directly on the card, ensuring that sensitive biometric information is never stored in the cloud. This on-card approach enables secure and convenient authentication with a simple touch, replacing traditional PINs and passwords. The solutions are certified by major payment networks like Visa and Mastercard and are compliant with FIDO standards for strong online authentication, offering protection against phishing and other cyber threats for both payment and access control systems.

Recent filings

Filing Released Lang Actions
Extraordinary general meeting in IDEX Biometrics held on 9 December 2022
AGM Information Classification · 99% confidence The document explicitly discusses an 'Extraordinary general meeting' (EGM) held on December 9, 2022. It details that resolutions were passed, specifically concerning the issuance of Tranche 2 shares from a private placement, which resulted in a change to the company's share capital. While it mentions the minutes will be available later, the core content is the outcome and resolutions of a shareholder meeting. This aligns best with the 'AGM Information' category (AGM-R), as EGMs are a type of general meeting, and the document reports the results and key decisions made during that meeting.
2022-12-09 English
Disclosure of Voting Rights in IDEX Biometrics Chair Morten Opstad - 08 December 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly details the voting rights held by the Chair of the Board, Morten Opstad, specifically in relation to an upcoming Extraordinary General Meeting (EGM) on December 09, 2022. It lists the total number of shares and percentage of capital he controls via proxy. This content directly relates to the declaration of voting rights and shareholder control mechanisms, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is an announcement *before* the EGM, it is a formal disclosure of voting power relevant to that meeting.
2022-12-08 English
Disclosure of Voting Rights in IDEX Biometrics Chair Morten Opstad - 07 December 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly details the voting rights held by the Chair of the Board, Morten Opstad, specifically in relation to an upcoming Extraordinary General Meeting (EGM) on December 9, 2022. It quantifies the number of shares and percentage of capital he can represent via proxy. This content directly relates to the declaration of voting rights and share representation for a general meeting, which aligns precisely with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is a disclosure *before* the meeting, it is a formal announcement concerning voting rights, making DVA the most appropriate classification over general regulatory filings (RNS) or director dealings (DIRS), as the focus is on voting power.
2022-12-07 English
Disclosure of Voting Rights in IDEX Biometrics Chair Morten Opstad - 06 December 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly discusses the 'Disclosure of Voting Rights' held by the Chair of the Board, Morten Opstad, specifically in relation to an 'Extraordinary General Meeting on 09 December 2022'. This type of filing details insider transactions or holdings relevant to shareholder votes. While it involves a director (which might suggest DIRS), the context is specifically about voting rights disclosure leading up to a general meeting. The closest fit among the provided definitions is 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it pertains directly to voting rights disclosure, even if it precedes the final results. It is not a general director's dealing (DIRS) which usually focuses on the transaction itself, nor is it a proxy solicitation (PSI) or AGM material (AGM-R). Given the focus on voting rights disclosure, DVA is the most appropriate classification.
2022-12-06 English
Registration of share capital increase in IDEX Biometrics - 5 Dec 2022
Capital/Financing Update Classification · 98% confidence The document explicitly announces the 'Registration of share capital increase' and details the resulting change in the company's share capital (NOK 167,637,217.35 divided into 1,117,581,449 shares). This directly relates to a change in the company's capital structure following the exercise of subscription rights. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not a general announcement of a report (RPA/RNS), nor is it a transaction in own shares (POS), which usually refers to buybacks/sales, although this is related to issuance, the primary focus is the capital structure update.
2022-12-05 English
Accomplish Financial launches innovative biometric card solution from IDEX Biometrics
Regulatory Filings Classification · 100% confidence The document is a press release dated December 1, 2022, announcing a partnership between IDEX Biometrics and Accomplish Financial to launch biometric payment cards. It details a business development and product launch, including quotes from executives and information about the companies involved. This type of announcement, which is not a formal regulatory filing (like 10-K, IR, or ER) but rather a general corporate update intended for investors and the public, best fits the 'Regulatory Filings' (RNS) category as a general corporate announcement, or potentially a 'Capital/Financing Update' (CAP) if the focus was on funding, but here it is clearly a product/partnership announcement. Since there is no specific category for 'Press Release' or 'Partnership Announcement', and it is not a core financial report, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback, although it is a very specific type of announcement. Given the content is a news announcement about a business development, RNS is the standard catch-all for non-standard regulatory news releases.
2022-12-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.